Hypohidrotic ectodermal dysplasia (HED) is characterized by defective ectodermal organ development. This includes the salivary glands (SGs), which have an important role in lubricating the oral cavity. In humans and mice, HED is caused by mutations in Ectodysplasin A (Eda) pathway genes. Various phenotypes of the mutant mouse Eda Ta/Ta , which lacks the ligand Eda, can be rescued by maternal injection or in vitro culture supplementation with recombinant EDA. However, the response of the SGs to this treatment has not been investigated. Here, we show that the submandibular glands (SMGs) of Eda Ta/Ta mice exhibit impaired branching morphogenesis, and that supplementation of Eda Ta/Ta SMG explants with recombinant EDA rescues the defect. Supplementation of Edar dlJ/dlJ SMGs with recombinant Sonic hedgehog (Shh) also rescues the defect, whereas treatment with recombinant Fgf8 does not. This work is the first to test the ability of putative Eda target molecules to rescue Eda pathway mutant SMGs. Developmental Dynamics 239:2674-2684,
INTRODUCTION
Mutations in Ectodysplasin A (Eda) pathway genes cause hypohidrotic ectodermal dysplasia (HED). Ectodermal dysplasia encompasses a group of disorders characterized by defective development of ectodermally derived structures such as the hair, teeth, and exocrine glands (Clarke et al., 1987) . EDA encodes the tumor necrosis factor (TNF) -like ligand EDA A1 (Srivastava et al., 1997) . EDA A1 signals by means of its receptor EDAR and an intracellular adaptor protein EDAR-ADD (Headon et al., 2001) , and is thought to instigate downstream activation of NFkB (Kumar et al., 2001) .
EDA can also undergo alternative splicing to produce EDA-A2 (Srivastava et al., 1997) , although the biological function of this splice variant is unknown. Recessive mutations in EDA are responsible for X-linked HED, the most common form of HED (Kere et al., 1996) , while dominant and recessive mutations in EDAR and EDARADD have been found in families carrying autosomal HED (Monreal et al., 1999; Headon et al., 2001 (Srivastava et al., 1997; Monreal et al., 1999; Headon et al., 2001 ) exhibit a similar phenotype to human HED in that the hair, teeth, and exocrine glands are impaired (Falconer et al., 1951; Grü neberg, 1965 Grü neberg, , 1971 Claxton, 1967; Blecher et al., 1983) . The role of Eda signaling in hair and tooth development are thriving areas of research, whereas research into the role of Eda signaling in exocrine gland development, in particular that of the salivary glands (SGs), is relatively neglected and warrants further investigation.
SGs have an important role in providing lubrication for digestion and protection of the oral cavity. HED patients demonstrate reduced whole saliva flow (Nordgarden et al., 2001) leading to xerostomia (dry mouth), further damage to an already compromised dentition and a reduced quality of life. Mammals have three pairs of major SGs that produce approximately 90% of total saliva (reviewed in Tucker, 2007) : the submandibular (SMG) and sublingual (SLG) glands, situated under the tongue with ducts secreting into the floor of the mouth, and the parotid at the back of the mouth in between the upper and lower jaw, with ducts secreting saliva into the inner cheek.
Of the various SG types, the murine SMG is the most studied and its development has been depicted in stages (Jaskoll and Melnick, 1999) . The developing SMG consists of ectodermally derived epithelial branches enclosed within a capsule of cranial neural crest derived mesenchyme (Jaskoll et al., 2002) . The SMG is first visible at embryonic day (E) 11.5 (prebud stage) appearing as a thickening of the oral epithelium next to the tongue. By E12.5 (initial bud stage), the epithelial thickening has protruded into the underlying mesenchyme, forming a bud that proliferates and undergoes branching morphogenesis to form several branches by E14.5 (pseudoglandular stage). Lumina begin to form in the presumptive ducts and end buds (the presumptive acini) at approximately E15.5 (canalicular stage), and the first secretory product can be detected from around E17.5 (terminal differentiation stage; Melnick and Jaskoll, 2000) .
Eda is expressed in the mesenchyme and Edar in the epithelium of the developing SMG at E13 and E14 (Pispa et al., 2003) , although the expression of Edaradd has not been described. In Eda Ta/Ta and Edar dlJ/dlJ adults, the SMGs are hypoplastic with a reduced number of ductal and acinar structures (Blecher et al., 1983; Jaskoll et al., 2003) . Regarding the developmental origin of this phenotype, the classical study of gland development in Eda Ta/Ta states that the embryonic SMGs are unaffected (Grü -neberg, 1971 ), but it has been reported recently that Eda Ta/Ta SMGs exhibit reduced branching and developmental delay from E13 (Melnick et al., 2009 ). Here, we provide an analysis of Eda Ta/Ta and wild-type (WT) littermate SMGs to build on this data. We also study the SMGs of embryos heterozygous for Eda mutation, as female Eda Ta/þ carriers exhibit defective tooth development, particularly in the upper jaw (Charles et al., 2009) .
Rescue of aspects of the Eda Ta/Ta phenotype has been achieved using several methods. Transgenic overexpression of Eda A1 driven by the CMV promoter leads to the rescue of the Eda Ta/Ta hair and sweat gland phenotypes as well as hypodontia (Srivastava et al., 2001) . Similarly, expression of an Eda A1 transgene in a tetracycline regulated conditional mouse model rescued sweat glands and hair development in Eda Ta/Ta , but the developmental timing of transgene activation is crucial and specific for each organ (Cui et al., 2009 ). Injection of a recombinant form of EDA A1 given to pregnant Eda Ta/ Ta mice in a series beginning at E11 leads to the almost complete rescue of the organs affected in the developing embryos (Gaide and Schneider, 2003) , although the effect on the SGs was not documented. In vitro, supplementation of Eda Ta/Ta skin cultures with recombinant EDA A1 rescues hair placode development (Mustonen et al., 2004) , while EDA A1 addition to WT SMG cultures increases branching and enhances NFkB activation (Jaskoll et al., 2003) . It follows that it may be possible to rescue Eda Ta/Ta SMGs in culture by recombinant EDA A1 supplementation, and here we show that this is achievable during both early and later branching morphogenesis, an encouraging finding for future attempts to correct SG defects in HED patients.
Recent years have seen considerable progress in identifying the genes regulated by Eda signaling. Notably, treatment of embryonic Eda Ta/Ta skin cultures with recombinant EDA A1 results in rapid and significant upregulation of Shh (Pummila et al., 2007) . Furthermore, recent quantitative polymerase chain reaction (qPCR) profiling has revealed downregulation of Shh in Eda Ta/Ta SMGs in comparison with WT SMGs (Melnick et al., 2009 
RESULTS

Edar and Edaradd Are Expressed From the Earliest Stages of SMG Development
The expression of Eda and Edar has been investigated at E13 and E14 in the SMGs (Pispa et al., 2003) , but expression during the earliest stages of SMG development has not been studied, nor has Edaradd expression been assessed at any stage. Therefore, we investigated the expression of Eda pathway genes at early stages of SMG development by in situ hybridization, concentrating on the expression of Edar and Edaradd, because the expression of these genes likely reflects the location at which the pathway is acting. At E11.5, Edar was found to be strongly expressed in the oral epithelial thickenings of the developing SMG and in the developing SMG bud at E12.5 (Fig. 1A,B) . Edaradd expression was also confined to the epithelium of the developing SMG from E12.5-E15.5 (Fig. 1C-F (Blecher et al., 1983; Jaskoll et al., 2003) . To determine the embryonic stage at which this defect originates, we chose to assess the mutant glands after dissection rather than in histological sections to evaluate the size and morphology of the glands accurately. E13.5 WT, Eda Ta/þ , and Eda Ta/Ta littermate SMGs (n ¼ 35 pairs in total from 3 litters) were examined, and we found no significant difference in branch number between any of the genotypes at this stage. However, we found a high level of morphological variation among the Eda Ta/Ta SMGs, and were able to define 3 morphotypes based on developmental stage and number of branches ( Fig. 2A-C 
Eda
Ta/Ta SMG phenotype. Furthermore, Eda appears to be consistently dispensable for initiation and in many cases for the early development of the SMG.
To determine whether Eda signaling plays a role in SMG branching morphogenesis, we next compared the development of precisely stage matched E13.5 WT and Eda Ta/Ta littermate SMGs for 72 hr in vitro. We found that Eda Ta/Ta SMGs exhibited visibly less branching when compared with WTs. The effect is apparent after 24 hr of culture when the Eda Ta/Ta gland displays less cleft formation than WTs (Fig. 3A-D) . After 72 hr of development, Eda Ta/Ta SMGs had formed markedly fewer branches in comparison with stage matched WT littermates (Fig. 3A,B ). This observation is supported by histological analysis of E15 WT and Eda Ta/Ta SMGs ( Fig. 3F ,G). In the WT SMG at E15, the epithelial branches begin to hollow out to form lumen (Fig. 3F) ; ductal lumen were found to be developing as normal in the mutant SMGs at E15 (Fig. 3G ), indicating that the branching defect is not due to overall developmental delay of the gland.
Traditionally, quantification of SMG branching is achieved by counting the number of buds present in SMG explants at a defined time point, and dividing this by the number of buds present at the onset of the culture period. The result is termed the Spooner ratio (Spooner and Bassett, 1989) and gives a measure of the extent of branching that has taken place in a particular explant over a defined time period. 
SMGs In Vitro
Recombinant EDA A1 supplementation rescues primary hair follicle development in Eda Ta/Ta skin explants (Mustonen et al., 2004) . We attempted to rescue the branching defect identified in embryonic Eda Ta/Ta and Eda Ta/þ SMGs by EDA A1 supplementation in vitro. E13.5 SMGs were initially selected because this stage precedes the appearance of the branching defect. We chose to supplement the glands with 100 ng/ml EDA A1 because this concentration rescues primary hair placode development in Eda Ta/Ta skin in vitro (Mustonen et al., 2004) .
Before attempting SMG rescue experiments, it was necessary to test our batch of EDA A1 to confirm functionality. Dorsal skin explants from E13.5 Eda Ta/Ta embryos were treated with EDA A1 for 24 hr to rescue primary hair placodes, which do not develop in Eda Ta/Ta (Mustonen et al., 2004; Mou et al., 2006 SMGs from the same embryo were reserved in pairs. From each pair, one SMG was treated with 100 ng/ml EDA A1 and its counterpart from the same embryo was cultured in the absence of EDA A1. After 72 hr, E13.5 SMGs supplemented with 100 ng/ml EDA A1 demonstrated visibly augmented branching (Fig. 4B ) compared with their unsupplemented control pairs (Fig. 4A ) and appeared comparable in branch number to WT littermate SMGs (Fig. 4B,C) . In fact, more cleft formation and budding was visible in the treated glands (Fig. 4E ) compared with their control pairs (Fig. 4D) as early as 24 hr into the culture period. Calculation of Spooner ratio and paired t-test revealed a statistically significant 36% (P ¼ 0.02) mean increase in branching of the supplemented explants compared with their unsupplemented pairs after 24 hr, and an 84% (P ¼ 0.001) mean increase after 48 hr. Comparison of Spooner ratios at all time points between the WT, treated, and untreated groups of glands showed that the branching defect seen in Eda Ta/Ta SMGs was fully rescued after only 24 hr of supplementation with 100 ng/ml EDA A1 (Fig. 4F) . With addition of fresh EDA A1 daily, the rescue was maintained with an absence of excess branching or negative effects for a further 48 hr at which point the experiment was terminated. Rescue of the branching phenotype and an absence of negative effects was apparent in the treated SMGs from all morphotype groups, indicating that Eda Ta/Ta SMGs can be treated with 100 ng/ml EDA A1 from an early stage of development to achieve rescue.
Recombinant EDA A1-mediated rescue of other ectodermal structures affected by the Eda mutation is highly stage dependent. To determine whether the SMGs could be rescued later in development, E15.5 Eda Ta/Ta SMGs were cultured with 500 ng/ml EDA A1 (a high concentration to ensure adequate penetration of the larger explants). After 24 hr, the EDA A1-treated explants exhibited a mean 19% greater (P ¼ 0.01, paired t-test) Spooner ratio compared with their untreated pairs (Fig. 5A-D SMGs. These mice lack functional Edar, and we considered them the best system for these experiments because the possibility of activating signaling downstream of the Eda pathway through Edar is abolished.
Before attempting rescue with Shh-N, it was necessary to confirm activation of the expected developmental pathway by Shh-N in our SMG cultures. E13.5 WT SMG explants were cultured for 24 hr with 1.5 mg/ml Shh-N, a concentration determined by dose response experiment to preclude toxicity on the developing gland (data not shown) and processed for wholemount in situ hybridization of Gli1 or Ta/Ta / Eda Ta/þ group and 100 ng/ml-treated group means (unpaired t-test). Error bars depict one standard error 6 mean. Scale bar ¼ 200 mm in A (applies in A-C), 100 mm in D (applies in D,E). 
Developmental Dynamics
Ptc1, known transcriptional targets of Shh signaling (Ingham and McMahon, 2001 ). Up-regulation of both genes was observed in explants treated with Shh-N (Supp. Fig. S2A-D) . Within the same period of color development, control SMGs showed no signal (Shh pathway components are normally expressed at very low levels in the SMGs). For the rescue experiments, E13.5 Edar dlJ/dlJ SMGs were cultured for 24 hr with 1.5 mg/ml Shh-N peptide. After 24 hr in culture, the Shh-N-treated explants exhibited a mean 58% greater (P ¼ 0.004, paired t-test) Spooner ratio compared with their untreated pairs (Fig. 6) , an improved increase in branching on that achieved by application of EDA A1 to E13.5 Eda Ta/Ta SMGs for 24 hr (36%). Exogenous Shh is, therefore, sufficient to rescue the branching phenotype in Edar dlJ/dlJ SMG explants, and like EDA A1-mediated rescue, is successful within 24 hr.
Fgf8 is a potential target of Eda signaling in the SMGs, because qPCR has revealed down-regulation of Fgf8 in Eda Ta/Ta SMGs (Melnick et al., 2009) . We tested whether application of exogenous Fgf8 was sufficient to rescue Edar dlJ/dlJ SMGs in a similar manner to EDA A1 and Shh. E13.5 Edar dlJ/dlJ SMGs were treated with 200 ng/ml Fgf8, a concentration shown by Jaskoll et al. (2004b) to increase branching in WT SMG explants after 72 hr in culture. After 24 hr in culture, we observed no difference in branch number between our Fgf8-treated Edar dlJ/dlJ SMGs and their untreated pairs (Fig. 7) . We allowed some of the explants to continue to develop for a further 48 hr and found no change in branch number in response to Fgf8 treatment, although we noticed that the treated explants appeared larger overall than their untreated pairs (Fig. 7A,B) . We quantified this by measuring the surface area of the epithelial portion of the explant, and dividing this value by branch number, to give a mean surface area per end bud. We found that the buds in the Fgf8-treated explants were a mean 24% larger than those of their untreated pair explants (P ¼ 0.007, paired t-test; Fig.  7C ). Fgf8 application alone is, therefore, not sufficient to rescue branching in Edar dlJ/dlJ SMGs, but appears to increase end bud size.
DISCUSSION Eda Signaling Is Required for Normal SMG Branching Morphogenesis
Analysis of the expression of Edar and Edaradd revealed that these key constituents of the Eda pathway are expressed from the earliest stages of SMG development-earlier than previously reported. Edar is expressed in the thickening and budding oral epithelium of the developing SMG, which in terms of the location of expression agrees with the work of Pispa et al. (2003) who demonstrated Edar expression in the epithelium of the branching SMG at E13 and E14. In the present work, the expression of Edaradd is investigated for the first time in the developing SMG, and is shown to be confined to the epithelium from early stages of development through branching morphogenesis. The expression of Edaradd mirrors that of Edar, suggesting that Edaradd interacts with Edar in the developing SMGs as in other ectodermal organs such as the tooth and hair follicles (Headon et al., 2001) .
Given that the Eda pathway is expressed from the earliest stages of SMG development, it was reasonable to expect the appearance of a defect early in the development of the SMG. We show that E13.5 Eda Ta/Ta SMGs in fact exhibit high morphological variation in comparison with their WT littermates. This variability is not surprising given that a similar phenomenon exists with respect to the Eda Ta/Ta tooth phenotype; the cusp morphology of the teeth is variable, and the third molar is missing in some but not all cases (Grü neberg, 1967) . The palatal rugae of Eda Ta/Ta mice have also been shown to exhibit high phenotypic variability in comparison with WTs (Charles et al., 2007) . A similar high variability in the Eda Ta/Ta SMG may explain why the original studies by Grü neberg (1971) found that the embryonic major SGs were unaffected, whereas results from Melnick et al. (2009) show that the Eda Ta/Ta SMG is characterized by hypoplasia and developmental delay from E13.
Our analyses of E13. initiation (Pispa et al., 1999; Tucker et al., 2000; Laurikkala et al., 2002) . These data, along with the present work, suggest some redundancy of the pathway. The TNF receptor Troy acts redundantly with Edar in secondary hair follicle development (Pispa et al., 2008) and it would be interesting to investigate the role of Troy in SMG development. We also show that embryonic Eda Ta/Ta and Eda Ta/þ SMGs exhibit a similar branching defect. It can be hypothesized that the X-chromosome inactivation effect in female heterozygous carriers of the X-linked Eda mutation leads to a reduced level of Eda availability in Eda Ta/þ SMGs in comparison with WTs. This difference in expression level appears to have great consequences in SMG development, and this idea fits with data showing that human female carriers of XL-HED exhibit reduced saliva flow (Lexner et al., 2007) .
Eda
Ta/Ta SMGs Can Be
Rescued With Recombinant EDA A1 In Vitro
Supplementation of E13.5 Eda Ta/Ta
SMGs with 100 ng/ml EDA A1 results in rescue of the branching phenotype after 24 hr, with EDA A1 supplementation bringing about increased epithelial clefting and branch elongation. This agrees with data showing that exogenous EDA A1 applied to E14 WT SMGs in culture increases branching (Jaskoll et al., 2003) . We also show that recombinant EDA A1-mediated rescue is achievable later in branching morphogenesis at E15.5. Recombinant EDA A1-mediated rescue of other ectodermal structures affected by Eda mutation is highly stage dependent. For example, in experiments whereby the Eda Ta/Ta phenotype was rescued by maternal injection of recombinant EDA A1, molar morphogenesis could only be fully rescued by injections administered from early in development (Gaide and Schneider, 2003) . Our results show that the developing SMGs, unlike the developing teeth, are still able to respond to EDA A1 supplementation after the appearance of the Eda Ta/Ta phenotype, an encouraging finding for future attempts to correct SG defects in HED patients. (Pummila et al., 2007) , consistent with a later role for Shh in skin appendage development. In some cases, however, Shh overexpression is associated with tumor formation in the skin (Oro et al., 1997) . In our experiments, the morphology of SMGs treated with Shh appeared normal, with no indication of ectopic SMG formation or tumorigenesis. Therefore, our results are also consistent with a role for Shh in later stage development of ectodermal appendages.
qPCR data have indicated that Fgf8 is a target of Eda signaling in the SMGs (Melnick et al., 2009 ). We were unable to demonstrate rescue of Edar dlJ/dlJ SMG explants by Fgf8 supplementation, although we observed an increase in gland size. In embryonic Eda Ta/Ta tooth explants, cusp morphogenesis is partially rescued by exogenous Fgf10 (Pispa et al., 1999) , although it is unclear whether this is through a mechanism normally independent of Eda signaling, such as an increase in epithelial proliferation. It is possible that the effects we observed on
Fgf8 supplementation of Edar dlJ/dlJ
SMGs are due to a similarly generalized increase in proliferation, but it also seems plausible that Fgf8 is unable to act alone in the formation of branches and requires other factors for normal morphogenesis. It seems likely that Eda signaling controls a variety of different transcriptional targets in the SMGs, and future work which identifies how these different factors act in concert to control branching morphogenesis will be of interest.
EXPERIMENTAL PROCEDURES Animals
All Eda pathway mutant mice were on the FVB/N background. E13. Cr/Cr refer to homozygous animals. CD1 mice were bred to obtain stage matched control embryos where required. Pregnant females were killed by cervical dislocation and noon on the day of discovery of the vaginal plug was designated day 0.5 of development. Embryos were harvested, staged according to Theiler (1989) 
0 (reverse). These primers generated 509 bp (Eda), 343 bp (Y chromosome), and 159 bp (Actin) fragments.
The Edar mutant animals used in this study were of the downless Jackson strain which possess a recessive G to A point mutation within the Edar death domain . Genotype of E13.5 Edar dlJ/dlJ and Edar dlJ/þ embryos was determined by PCR analysis using Edarspecific primers, the forward primer containing a one nucleotide mismatch from the template DNA. The mismatch enabled the generation of a TaqI restriction site unique to the WT sequence. Primer sequences were 5 0 -TGAAAACATGGCGCCACCTTGTC-3 0 (forward, mismatch underlined), 5 0 -TCACTCACAGCTGTCGGTCGTG-3 0 (reverse). These primers generated a 309-bp product. Overnight restriction of Edar dlJ/dlJ product with TaqI (Sigma) at 65 C resulted in 142-bp and 167-bp fragments (due to a natural TaqI site within the PCR product), whereas restriction of Edar dlJ/þ product resulted in fragments of 167 bp, 142 bp, 120 bp, and 22 bp. Fragments were visualized on a 3% agarose gel. The mismatch primer was designed using dCAPS Finder 2.0 online software.
PCR cycling conditions were: 94 C 2 min 30 s, 94 C 30 s, 54 C 30 s, 72 C 1 min for 36 cycles.
Tissue Processing and Sectioning
Tissues were fixed in 4% paraformaldehyde at 4 C overnight and washed in PBS before dehydration in a methanol and isopropanol series, and clearing in 1,2,3,4-tetrahydronaphthalene. Cleared samples were incubated in paraffin wax at 65 C before embedding in moulds. Sections were cut to a thickness of 8 mm, mounted on glass slides (Superfrost Plus, VWR International) and dried on a 42 C hotblock overnight.
In Situ Hybridization
Radioactive in situ hybridization of 35 S-UTP-labeled Edar and Edaradd probes was performed as described in Tucker et al. (1999) . Edar was linearized with Bss HI and transcribed with T7. Edaradd was linearized with Spe 1 and transcribed with T3. Sections were counterstained with methyl green and photographed under darkfield.
Whole-mount in situ hybridization of digoxigenin-labeled Ptc1 and Gli1 probes was performed according to Wilkinson (1995) . For reliable comparison of expression levels between treated and control glands, explants were subjected to simultaneous and identical processing and color development. Color was developed for 5 hr (when a strong signal became apparent in Shh-N-treated explants) before photographing. Three explants were processed per treatment group and probe, and all explants within each group showed similar results. Gli1 was linearized with NotI and transcribed with T3. Ptc1 was linearized with Bam HI and transcribed with T3.
Whole-mount in situ hybridization of a digoxigenin-labeled Shh probe on skin explants was performed as described in Mou et al. (2006) .
Histology Staining
Sections were cleared with Histoclear, rehydrated through an ethanol series and washed in dH 2 O. Sections were stained with hemotoxylin and eosin (H&E) and differentiated in acid alcohol. After staining, sections were washed in dH 2 O, dehydrated through an ethanol series, cleared in xylene and coverslipped with DPX mounting medium.
Organ Culture
SMGs were dissected in complete culture medium and reserved in pairs to compare control and treated glands from the same embryo. Explants were mounted on membranes (BD Falcon cell culture inserts) and floated over culture medium in glass bottom dishes (MatTek Corporation). Medium for experimental explants was supplemented with recombinant Fc-EDA A1 (Gaide and Schneider, 2003) , Fgf8b, or Shh-N peptide (R&D Systems). Explants were cultured in a 37 C, 5% CO 2 incubator, photographed and the medium changed daily. Skin explant cultures to confirm recombinant EDA-A1 functionality were performed as described in Mou et al. (2006) .
Morphometric Analysis
The Spooner ratio (number of branches present at Â hr/number of branches present at 0 hr) (Spooner and Bassett, 1989) was calculated for each SMG by manually counting branch number using an image of the explant in WCIF ImageJ 1.37c. The Spooner ratios of treated and untreated explants from the same embryo were compared by paired ttest, and mean Spooner ratios for groups of explants were compared by unpaired t-test. Two-dimensional surface areas were calculated using an image of the explant in Image Pro 6.2: the polygon tool was used to draw carefully around the epithelial portion of the SMG (excluding main duct) and scale bars used to convert the surface area in pixels of the resultant shape to mm 2 . Data were analyzed and converted to charts using Microsoft Office Excel 2007. Box plots were constructed using Graphpad Prism 5. Statistically, the level of significance was taken as P < 0.05.
